CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.770
-0.080 (-4.32%)
Dec 5, 2025, 4:00 PM EST - Market closed
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $20.43 million as of December 5, 2025. Its market cap has decreased by -18.59% in one year.
Market Cap
20.43M
Enterprise Value
18.57M
1-Year Change
-18.59%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $20.43M, a decrease of -55.71%. That is a compound annual growth rate of -26.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 21.35M | -45.59% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |